<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35747600</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7090</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Journal of pain research</Title><ISOAbbreviation>J Pain Res</ISOAbbreviation></Journal><ArticleTitle>Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID.</ArticleTitle><Pagination><StartPage>1729</StartPage><EndPage>1748</EndPage><MedlinePgn>1729-1748</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/JPR.S365026</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Musculoskeletal (MSK) pain is being increasingly reported by patients as one of the most common persistent symptoms in post-COVID-19 syndrome or Long COVID. However, there is a lack of understanding of its prevalence, characteristics, and underlying pathophysiological mechanisms. The objective of this review is to identify and describe the features and characteristics of MSK pain in Long COVID patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The narrative review involved a literature search of the following online databases: MEDLINE (OVID), EMBASE (OVID), CINAHL, PsyclNFO, and Web of Science (December 2019 to February 2022). We included observational studies that investigated the prevalence, characteristics, risk factors and mechanisms of MSK pain in Long COVID. After screening and reviewing the initial literature search results, a total of 35 studies were included in this review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The overall reported prevalence of MSK pain in Long COVID ranged widely from 0.3% to 65.2%. The pain has been reported to be localized to a particular region or generalized and widespread. No consistent pattern of progression of MSK pain symptoms over time was identified. Female gender and higher BMI could be potential risk factors for Long COVID MSK pain, but no clear association has been found with age and ethnicity. Different pathophysiological mechanisms have been hypothesized to contribute to MSK pain in Long COVID including increased production of proinflammatory cytokines, immune cell hyperactivation, direct viral entry of neurological and MSK system cells, and psychological factors.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">MSK pain is one of the most common symptoms in Long COVID. Most of the current literature on Long COVID focuses on reporting the prevalence of persistent MSK pain. Studies describing the pain characteristics are scarce. The precise mechanism of MSK pain in Long COVID is yet to be investigated. Future research must explore the characteristics, risk factors, natural progression, and underlying mechanisms of MSK pain in Long COVID.</AbstractText><CopyrightInformation>&#xa9; 2022 Khoja et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Khoja</LastName><ForeName>Omar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-3978-6253</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Silva Passadouro</LastName><ForeName>B&#xe1;rbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4668-093X</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulvey</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6357-3848</Identifier><AffiliationInfo><Affiliation>Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-8940-5036</Identifier><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astill</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9443-6934</Identifier><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ai Lyn</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-9158-7243</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>J Pain Res</MedlineTA><NlmUniqueID>101540514</NlmUniqueID><ISSNLinking>1178-7090</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic pain</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>2</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35747600</ArticleId><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="doi">10.2147/JPR.S365026</ArticleId><ArticleId IdType="pii">365026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence, Practitioners RC of G, Scotland HI. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guidel; 2020:1&#x2013;35. Available from:
https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742. Accessed June
9, 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Headquarters (HQ). A clinical case definition of post COVID-19 condition by a Delphi consensus; 2021. Available from:
https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed June
9, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Pawelek P. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK; 2022. Available from:
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/alldatarelatingtoprevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk. Accessed June
9, 2022.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. SSRN Electron J. 2021. doi:10.2139/ssrn.3820561</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3820561</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370. doi:10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2020;93:1013&#x2013;1022. doi:10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill SL, Sivan M. The relationship between physical activity and long COVID: a Cross-Sectional Study. Int J Environ Res Public Heal. 2022;19(9). doi:10.3390/ijerph19095093</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095093</ArticleId><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies RM, O&#x2019;Sullivan O, Senaratne KPP, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949&#x2013;959. doi:10.1136/bjsports-2020-102596</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2020-102596</ArticleId><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, H&#xe4;llqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. The long tail of Covid-19&#x201d; - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2020;9:1349. doi:10.12688/f1000research.27287.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.2</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon-Ceron D, Slama D, De Broucker T, et al. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infect. 2021;82(2):E1&#x2013;E4. doi:10.1016/j.jinf.2020.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Parkin A, Makower S, Greenwood DC. Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: a cross-sectional evaluation from a community COVID rehabilitation service. J Med Virol. 2021. doi:10.1002/jmv.27456</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27456</ArticleId><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="pubmed">34783052</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrot S, Cohen M, Barke A, Korwisi B, Rief W, Treede R-D. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain. 2019;160(1):77&#x2013;82. doi:10.1097/j.pain.0000000000001389</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001389</ArticleId><ArticleId IdType="pubmed">30586074</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-las-Penas C, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: a case-control study. Cephalalgia. 2021;41(13):1332&#x2013;1341. doi:10.1177/03331024211020404</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211020404</ArticleId><ArticleId IdType="pmc">PMC8212025</ArticleId><ArticleId IdType="pubmed">34134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2021;396(10267):2006&#x2013;2017. doi:10.1016/S0140-6736(20)32340-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32340-0</ArticleId><ArticleId IdType="pmc">PMC7811204</ArticleId><ArticleId IdType="pubmed">33275908</ArticleId></ArticleIdList></Reference><Reference><Citation>Versus Arthritis. The state of musculoskeletal health 2021; 2021. Available from:
https://www.versusarthritis.org/policy/resources-for-policy-makers/musculoskeletal-calculator/. Accessed June
9, 2022.</Citation></Reference><Reference><Citation>Bergman S, Herrstr&#xf6;m P, H&#xf6;gstr&#xf6;m K, Petersson IF, Svensson B, Jacobsson LT. Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol. 2001;28(6):1369&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pubmed">11409133</ArticleId></ArticleIdList></Reference><Reference><Citation>Picavet HSJ, Schouten JSAG. Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC(3)-study. Pain. 2003;102(1&#x2013;2):167&#x2013;178. doi:10.1016/s0304-3959(02)00372-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0304-3959(02)00372-x</ArticleId><ArticleId IdType="pubmed">12620608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimas M, Ayala A, Sanz B, Agull&#xf3;-Tom&#xe1;s MS, Escobar A, Forjaz MJ. Chronic musculoskeletal pain in European older adults: cross-national and gender differences. Eur J Pain. 2018;22(2):333&#x2013;345. doi:10.1002/ejp.1123</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1123</ArticleId><ArticleId IdType="pubmed">29235193</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Kinnear L, Tan A, McGonagle D. Risk factors and predictors of long covid or post-COVID-19 syndrome. J R Coll Physicians. 2022;45:e34.</Citation></Reference><Reference><Citation>T&#xfc;z&#xfc;n EH. Quality of life in chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21(3):567&#x2013;579. doi:10.1016/j.berh.2007.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2007.03.001</ArticleId><ArticleId IdType="pubmed">17603000</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain. 2000;84(1):95&#x2013;103. doi:10.1016/S0304-3959(99)00187-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(99)00187-6</ArticleId><ArticleId IdType="pubmed">10601677</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13(8):715&#x2013;724. doi:10.1016/j.jpain.2012.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2012.03.009</ArticleId><ArticleId IdType="pubmed">22607834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Rayner C, Delaney B. Fresh evidence of the scale and scope of long covid. BMJ. 2021;373:n853. doi:10.1136/bmj.n853</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n853</ArticleId><ArticleId IdType="pubmed">33795224</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohiuddin Chowdhury ATM, Karim MR, Ali MA, Islam J, Li Y, He S. Clinical characteristics and the long-term post-recovery manifestations of the COVID-19 patients&#x2014;A prospective multicenter cross-sectional study. Front Med. 2021;8:1&#x2013;10. doi:10.3389/fmed.2021.663670</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.663670</ArticleId><ArticleId IdType="pmc">PMC8416537</ArticleId><ArticleId IdType="pubmed">34490284</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares FHC, Kubota GT, Fernandes AM, et al. Prevalence and characteristics of new-onset pain in COVID-19 survivors, a controlled study. Eur J Pain. 2021;25:1342&#x2013;1354. doi:10.1002/ejp.1755</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1755</ArticleId><ArticleId IdType="pmc">PMC8013219</ArticleId><ArticleId IdType="pubmed">33619793</ArticleId></ArticleIdList></Reference><Reference><Citation>Adnan JW, Saleemi H, Shafqat A, Arif M, Hamid K. Tendency of post COVID muscle and joint pains. Med Forum Mon. 2021;32(4):161&#x2013;163.</Citation></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2021. doi:10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlgren C, Divanoglou A, Larsson M, et al. Rehabilitation needs following COVID-19: five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms. EClinicalMedicine. 2022;43:1&#x2013;14. doi:10.1016/j.eclinm.2021.101219</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101219</ArticleId><ArticleId IdType="pmc">PMC8645256</ArticleId><ArticleId IdType="pubmed">34901798</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, G&#xfc;neri FD, Karde&#x15f; S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. 2022;41(1):289&#x2013;296. doi:10.1007/s10067-021-05942-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Bileviciute-ljungar I, Norrefalk J, Borg K. Pain burden in post-COVID-19 syndrome following mild COVID-19 infection. Journal of Clinical Medicine. 2022;11(3):771. doi:10.3390/jcm11030771</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030771</ArticleId><ArticleId IdType="pmc">PMC8836662</ArticleId><ArticleId IdType="pubmed">35160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542&#x2013;02020. doi:10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H, et al. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73(3):e826&#x2013;e829. doi:10.1093/cid/ciab103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Leite VF, Rampim DB, Jorge VC, et al. Persistent symptoms and disability after COVID-19 hospitalization: data from a comprehensive telerehabilitation program. Arch Phys Med Rehabil. 2021;102(7):1308&#x2013;1316. doi:10.1016/j.apmr.2021.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC7943375</ArticleId><ArticleId IdType="pubmed">33711279</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, et al. Cerebral micro-structural changes in COVID-19 patients &#x2013; an MRI-based 3-month follow-up study: a brief title: cerebral changes in COVID-19. EClinicalMedicine. 2020;25(2):100484. doi:10.1016/j.eclinm.2020.100484</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263. doi:10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Leth S, Gunst JD, Mathiasen V, et al. Persistent symptoms in patients recovering from COVID-19 in Denmark. Open Forum Infect Dis. 2021;8(4):1&#x2013;7. doi:10.1093/ofid/ofab042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab042</ArticleId><ArticleId IdType="pmc">PMC7928683</ArticleId><ArticleId IdType="pubmed">33875970</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Rodriguez-Jimenez J, Fuensalida-Novo S, et al. Myalgia as a symptom at hospital admission by SARS-CoV-2 infection is associated to persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study. Pain. 2021. doi:10.1097/j.pain.0000000000002306</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002306</ArticleId><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdy R, Hussein M, Ragaie C, et al. Characteristics of headache attributed to COVID-19 infection and predictors of its frequency and intensity: a cross sectional study. Cephalalgia. 2020;40(13):1422&#x2013;1431. doi:10.1177/0333102420965140</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965140</ArticleId><ArticleId IdType="pmc">PMC7645600</ArticleId><ArticleId IdType="pubmed">33146038</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):1&#x2013;22. doi:10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A, Iqbal K, Arshad Ali S, et al. The COVID-19 sequelae: a cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus. 2021;2(2). doi:10.7759/cureus.13080</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13080</ArticleId><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199(2):113&#x2013;119. doi:10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Navarro-Santana M, Plaza-Manzano G, Palacios-Ce&#xf1;a D, Arendt-Nielsen L. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived to severe acute respiratory syndrome coronavirus 2 infection. Pain. 2021;Publish Ahead of Print. doi:10.1097/j.pain.0000000000002496</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers.&#x201d;. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085. doi:10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. ICD-11 for mortality and morbidity statistics; 2018. Available from:
https://icd.who.int/browse11/l-m/en. Accessed November
15, 2021.</Citation></Reference><Reference><Citation>Ursini F, Ciaffi J, Mancarella L, et al. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021;7(3):e001735. doi:10.1136/rmdopen-2021-001735</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-001735</ArticleId><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, Van, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol a J Pathol Soc Gt Britain Irel. 2004;203(2):631&#x2013;637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Muus C, Luecken MD, Eraslan G, et al. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nature Medicine. 2021;27:546&#x2013;559. doi:10.1038/s41591-020-01227-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01227-z</ArticleId><ArticleId IdType="pmc">PMC9469728</ArticleId><ArticleId IdType="pubmed">33654293</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekulic M, Harper H, Nezami BG, et al. Molecular detection of SARS-CoV-2 infection in FFPE samples and histopathologic findings in fatal SARS-CoV-2 cases. Am J Clin Pathol. 2020;154(2):190&#x2013;200. doi:10.1093/ajcp/aqaa091</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqaa091</ArticleId><ArticleId IdType="pmc">PMC7314275</ArticleId><ArticleId IdType="pubmed">32451533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AK, Demediuk L, Tay JY, et al. COVID-19 end-of-life care: symptoms and supportive therapy use in an Australian hospital. Intern Med J. 2021;51:1420&#x2013;1425. doi:10.1111/imj.15300</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.15300</ArticleId><ArticleId IdType="pmc">PMC8250873</ArticleId><ArticleId IdType="pubmed">33755283</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Schneider J, Greuel S, et al. Association between SARS-CoV-2 infection and immune-mediated myopathy in patients who have died. JAMA Neurol. 2021;78(8):948. doi:10.1001/jamaneurol.2021.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2004</ArticleId><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh J, Mukerji SS, Collens SI, et al. Skeletal muscle and peripheral nerve histopathology in COVID-19. Neurology. 2021;97(8):e849&#x2013;e858. doi:10.1212/WNL.0000000000012344</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012344</ArticleId><ArticleId IdType="pubmed">34099523</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper JE, Uner M, Priemer DS, Rosenberg A, Chen L. Muscle biopsy findings in a case of sars-cov-2-associated muscle injury. J Neuropathol Exp Neurol. 2021;80(4):377&#x2013;378. doi:10.1093/jnen/nlaa155</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlaa155</ArticleId><ArticleId IdType="pmc">PMC7799012</ArticleId><ArticleId IdType="pubmed">33355335</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;690. doi:10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitscheider L, Karolyi M, Burkert FR, et al. Muscle involvement in SARS&#x2010;CoV&#x2010;2 infection. Eur J Neurol. 2021;28(10):3411&#x2013;3417. doi:10.1111/ene.14564</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14564</ArticleId><ArticleId IdType="pmc">PMC7537196</ArticleId><ArticleId IdType="pubmed">32997370</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace V, Sebastianelli L, Ferrazzoli D, et al. Myopathy in COVID-19 critically ill patients: a consequence of hyperinflammation? Front Neurol. 2021;12:66. doi:10.3389/fneur.2021.625144</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.625144</ArticleId><ArticleId IdType="pmc">PMC7878532</ArticleId><ArticleId IdType="pubmed">33584530</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte&#x2010;Neto AN, Monteiro RAA, da Silva LFF, et al. Pulmonary and systemic involvement in COVID&#x2010;19 patients assessed with ultrasound&#x2010;guided minimally invasive autopsy. Histopathology. 2020;77(2):186&#x2013;197. doi:10.1111/his.14160</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14160</ArticleId><ArticleId IdType="pmc">PMC7280721</ArticleId><ArticleId IdType="pubmed">32443177</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard J, Leth S, Pedersen TH, et al. Myopathic changes in patients with long-term fatigue after COVID-19. Clin Neurophysiol. 2021;132(8):1974&#x2013;1981. doi:10.1016/j.clinph.2021.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.04.009</ArticleId><ArticleId IdType="pmc">PMC8102077</ArticleId><ArticleId IdType="pubmed">34020890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hameed S, Khan AF, Khan S. Electrodiagnostic findings in COVID-19 patients: a single center experience. Clin Neurophysiol. 2021;132(12):3019&#x2013;3024. doi:10.1016/j.clinph.2021.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.10.001</ArticleId><ArticleId IdType="pmc">PMC8513511</ArticleId><ArticleId IdType="pubmed">34717222</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Mills AJ, Kelley M, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflammation. 2022;9(3):e1146. doi:10.1212/NXI.0000000000001146</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747&#x2013;758. doi:10.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LW, Deng CH, Chen XH, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020;98(8):E951&#x2013;E959. doi:10.1111/aos.14472</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.14472</ArticleId><ArticleId IdType="pmc">PMC7276826</ArticleId><ArticleId IdType="pubmed">32421258</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1123&#x2013;1130. doi:10.1080/22221751.2020.1770129</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1770129</ArticleId><ArticleId IdType="pmc">PMC7473317</ArticleId><ArticleId IdType="pubmed">32475230</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Han J, Cheng X, et al. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients. Sci Rep. 2020;10(1):17718. doi:10.1038/s41598-020-73955-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73955-8</ArticleId><ArticleId IdType="pmc">PMC7573596</ArticleId><ArticleId IdType="pubmed">33077873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Wong P, Klein J, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463&#x2013;469. doi:10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong SWX, Fong S-W, Young BE, et al. Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open Forum Infectious Diseases. 2021;8(6):ofab156. doi:10.1093/ofid/ofab156</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab156</ArticleId><ArticleId IdType="pmc">PMC8083585</ArticleId><ArticleId IdType="pubmed">34095336</ArticleId></ArticleIdList></Reference><Reference><Citation>Binshtok AM, Wang H, Zimmermann K, et al. Nociceptors are interleukin-1&#x3b2; sensors. J Neurosci. 2008;28(52):14062&#x2013;14073. doi:10.1523/JNEUROSCI.3795-08.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3795-08.2008</ArticleId><ArticleId IdType="pmc">PMC2690713</ArticleId><ArticleId IdType="pubmed">19109489</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenn D, Richter F, Schaible H. Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin&#x2010;6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum. 2007;56(1):351&#x2013;359. doi:10.1002/art.22282</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22282</ArticleId><ArticleId IdType="pubmed">17195239</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol. 1992;107(3):660. doi:10.1111/j.1476-5381.1992.tb14503.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.1992.tb14503.x</ArticleId><ArticleId IdType="pmc">PMC1907751</ArticleId><ArticleId IdType="pubmed">1472964</ArticleId></ArticleIdList></Reference><Reference><Citation>Mailhot B, Christin M, Tessandier N, et al. Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases. J Exp Med. 2020;217(9). doi:10.1084/jem.20191430</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191430</ArticleId><ArticleId IdType="pmc">PMC7478735</ArticleId><ArticleId IdType="pubmed">32573694</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva RL, Lopes AH, Guimar&#xe3;es RM, Cunha TM. CXCL1/CXCR2 signaling in pathological pain: role in peripheral and central sensitization. Neurobiol Dis. 2017;105:109&#x2013;116. doi:10.1016/j.nbd.2017.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.06.001</ArticleId><ArticleId IdType="pubmed">28587921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-&#x3b1; induces ectopic activity in nociceptive primary afferent fibres. Neuroscience. 1997;81(1):255&#x2013;262. doi:10.1016/S0306-4522(97)00147-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(97)00147-4</ArticleId><ArticleId IdType="pubmed">9300418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierle DM, Aakre CA, Grach SL, et al. Central sensitization phenotypes in post acute sequelae of SARS-CoV-2 infection (PASC): defining the post COVID syndrome. J Prim Care Community Health. 2021;12:21501327211030824. doi:10.1177/21501327211030826</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211030826</ArticleId><ArticleId IdType="pmc">PMC8267019</ArticleId><ArticleId IdType="pubmed">34231404</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M, Del Gaudio A, Vittori A, et al. COVID-pain: acute and late-onset painful clinical manifestations in COVID-19&#x2013;molecular mechanisms and research perspectives. J Pain Res. 2021;14:2403. doi:10.2147/JPR.S313978</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S313978</ArticleId><ArticleId IdType="pmc">PMC8364364</ArticleId><ArticleId IdType="pubmed">34408485</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland AJ, Yousuf MS, Shiers S, Price TJ. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain. Pain Rep. 2021;6(1):1&#x2013;10. doi:10.1097/PR9.0000000000000885</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000885</ArticleId><ArticleId IdType="pmc">PMC7803673</ArticleId><ArticleId IdType="pubmed">33458558</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudman L, De Smedt A, Noppen M, Moens M. Is central sensitisation the missing link of persisting symptoms after COVID-19 infection? J Clin Med. 2021;10(23):5594. doi:10.3390/jcm10235594</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10235594</ArticleId><ArticleId IdType="pmc">PMC8658135</ArticleId><ArticleId IdType="pubmed">34884296</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipollaro L, Giordano L, Padulo J, Oliva F, Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J Orthop Surg Res. 2020;15:1&#x2013;7. doi:10.1186/s13018-020-01702-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13018-020-01702-w</ArticleId><ArticleId IdType="pmc">PMC7232908</ArticleId><ArticleId IdType="pubmed">32423471</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauw DJ, H&#xe4;user W, Cohen SP, Fitzcharles M-A, Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020;161(8):1694&#x2013;1697. doi:10.1097/j.pain.0000000000001950</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001950</ArticleId><ArticleId IdType="pmc">PMC7302093</ArticleId><ArticleId IdType="pubmed">32701829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020;125(4):436&#x2013;440. doi:10.1016/j.bja.2020.05.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.05.021</ArticleId><ArticleId IdType="pmc">PMC7261464</ArticleId><ArticleId IdType="pubmed">32560913</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira E, Ferreira M, Oliveira RKF. Mechanisms of exercise intolerance after COVID-19: new perspectives beyond physical deconditioning. J Bras Pneumol. 2021;47(5):19&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013534</ArticleId><ArticleId IdType="pubmed">34878057</ArticleId></ArticleIdList></Reference><Reference><Citation>Asmundson GJG, Katz J. Understanding the co&#x2010;occurrence of anxiety disorders and chronic pain: state&#x2010;of&#x2010;the&#x2010;art. Depress Anxiety. 2009;26(10):888&#x2013;901. doi:10.1002/da.20600</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/da.20600</ArticleId><ArticleId IdType="pubmed">19691031</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll LJ, Cassidy JD, C&#xf4;t&#xe9; P. Depression as a risk factor for onset of an episode of troublesome neck and low back pain. Pain. 2004;107(1&#x2013;2):134&#x2013;139. doi:10.1016/j.pain.2003.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2003.10.009</ArticleId><ArticleId IdType="pubmed">14715399</ArticleId></ArticleIdList></Reference><Reference><Citation>McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106(1&#x2013;2):127&#x2013;133. doi:10.1016/S0304-3959(03)00301-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3959(03)00301-4</ArticleId><ArticleId IdType="pubmed">14581119</ArticleId></ArticleIdList></Reference><Reference><Citation>Starkweather AR, Heineman A, Storey S, et al. Methods to measure peripheral and central sensitization using quantitative sensory testing: a focus on individuals with low back pain. Appl Nurs Res. 2016;29:237&#x2013;241. doi:10.1016/j.apnr.2015.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apnr.2015.03.013</ArticleId><ArticleId IdType="pubmed">26856520</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Halpin S, Gees J, et al. The self-report version and digital format of the COVID-19 Yorkshire rehabilitation scale (C19-YRS) for long covid or post-COVID syndrome assessment and monitoring. Adv Clin Neurosci Rehabil. 2021;20(3):8&#x2013;11. doi:10.47795/qroo4168</Citation><ArticleIdList><ArticleId IdType="doi">10.47795/qroo4168</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Wright S, Hughes S, Calvert M. Using condition specific patient reported outcome measures for long covid. BMJ. 2022;o257. doi:10.1136/bmj.o257</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o257</ArticleId><ArticleId IdType="pubmed">35091425</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K, Straudi S, Sien NY, Fayed N, Melvin JL, Sivan M. Applying the who ICF framework to the outcome measures used in the evaluation of long-term clinical outcomes in coronavirus outbreaks. Int J Environ Res Public Health. 2020;17(18):1&#x2013;15. doi:10.3390/ijerph17186476</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17186476</ArticleId><ArticleId IdType="pmc">PMC7558385</ArticleId><ArticleId IdType="pubmed">32899534</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Preston N, Parkin A, et al. The modified COVID-19 Yorkshire rehabilitation scale (C19-YRSm) patient-reported outcome measure for long covid or post-COVID syndrome. medRxiv. 2022. doi:10.1101/2022.03.24.22272892</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.24.22272892</ArticleId><ArticleId IdType="pmc">PMC9348420</ArticleId><ArticleId IdType="pubmed">35603810</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Baricich A, Patrucco F, et al. Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep. 2021;11(1):1&#x2013;10. doi:10.1038/s41598-021-01215-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-01215-4</ArticleId><ArticleId IdType="pmc">PMC8608998</ArticleId><ArticleId IdType="pubmed">34811387</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi:10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I, Hussein A, Amin MT, et al. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol. 2021;15(1). doi:10.1186/s43168-020-00049-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325(19):2015&#x2013;2016. doi:10.1001/jama.2021.5612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz LI, Garry K, Prete AM, et al. Six-month outcomes in patients hospitalized with severe COVID-19. J Gen Intern Med. 2021;36(12):3772&#x2013;3777. doi:10.1007/s11606-021-07032-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07032-9</ArticleId><ArticleId IdType="pmc">PMC8341831</ArticleId><ArticleId IdType="pubmed">34355349</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882. doi:10.1371/journal.pone.0243882</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2020;75:e13746&#x2013;e13746. doi:10.1111/ijcp.13746</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R, Rahman MM, Rassel MA, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021;16(4):e0249644. doi:10.1371/journal.pone.0249644</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradian ST, Parandeh A, Khalili R, Karimi L. Delayed symptoms in patients recovered from COVID-19. Iran J Public Health. 2020;49(11):2120&#x2013;2127. doi:10.18502/ijph.v49i11.4729</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijph.v49i11.4729</ArticleId><ArticleId IdType="pmc">PMC7917497</ArticleId><ArticleId IdType="pubmed">33708732</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383. doi:10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76(4):405&#x2013;407. doi:10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV, Casati M, et al. Surviving COVID-19 in bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021;2. doi:10.1017/S0950268821000145</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89&#x2013;95. doi:10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Cai J, Sun W, et al. Do post-COVID-19 symptoms exist? A longitudinal study of COVID-19 sequelae in Wenzhou, China. Ann Med Psychol. 2021;179(9):818&#x2013;821. doi:10.1016/j.amp.2021.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amp.2021.03.003</ArticleId><ArticleId IdType="pmc">PMC7934689</ArticleId><ArticleId IdType="pubmed">33688094</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>